Skip to main content

Find Clinical Trials

Home
Conditions
Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN

Clinical trial condition

Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN

Explore clinical trials studying Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN trial results

Recruiting

Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial

NCT07165769

Conditions: Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details